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Abstract
Objective: To evaluate the performance of phage amplified biologically assay (PhaB) for detecting tuberculosis (TB) in
sputum in the pulmonary tuberculosis (PTB) patients.
Methods: Shanghai Tuberculosis Key Laboratory of Shanghai Pulmonary Hospital participated in the project in collaboration
with the laboratories of six hospitals and a total of 1660 eligible participants (1351 PTB patients and 309 non-TB patients)
were included in the study. The sputum samples from the participants were detected by smear microscopy, PhaB, and
Lo ¨wenstein-Jensen (L-J) culture method, respectively.
Results: The overall sensitivity of PhaB were higher than that of L-J culture and smear microscopy (p,0.05). The sensitivity
of PhaB for detecting smear-negative specimens was obviously higher than that of L-J culture (p,0.05). Compared with L-J
culture, the overall sensitivity, specificity, PPV, NPV, ACC and Kappa value of PhaB were 98.4 (95% Cl: 96.9–99.3), 71.6 (95%
Cl: 68.4–74.6), 67.7, 98.7, 81.7% and 0.643, respectively. The detection median time of PhaB only needed 48 hours, which
was significantly less than that (31 days) of L-J culture method.
Conclusion: PhaB method is a rapid and sensitive method for detecting TB in sputum in PTB patients; especially for the
diagnosis of smear-negative PTB, PhaB method is obviously more sensitive than L-J culture method.
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Introduction
Tuberculosis (TB) is a common and deadly infectious disease that
is caused by Mycobacterium tuberculosis (MTB). The World Health
Organization estimated that, the global burden of disease caused by
TB in 2009 are as follows: 9.4 million incident cases (range, 8.9
million–9.9 million), 14 million prevalent cases (range, 12 million–
16 million), 1.3 million deaths among HIV-negative people (range,
1.2 million–1.5 million) and 0.38 million deaths among HIV-
positive people (range, 0.32 million–0.45 million). Most cases were
in the South-East Asia, African and Western Pacific regions (35, 30
and 20%, respectively) [1]. China is a country of high incidence of
TB, with about 4.5 million TB patients, ranking second in the world
[1]. Undoubtedly, a rapid and accurate detection is vital to TB
diagnosis, treatment, prevention and control, which has been the
focus of the study for TB worldwide [2,3]. Phage amplified
biologically assay (PhaB) was an established diagnostic technique for
the detection of TB in recent years [4–6]. PhaB delicately utilized
the ability of mycobacteriophages to infect mycobacteria to detect
TB. In detail, mycobacteriophages internalized TB could be
protected from chemical inactivation and replicated, which could
lyse mycobacteria and the progeny phages were released. And the
released phages can lyse fast-growing Mycobacterium smegmatis
(indicator cell)added subsequently. As a result, on the agar plate
would appear translucent plaques. The testing result could be
judged from the observation of the plaques [7]. Figure 1 show the
primaryproceduresofPhaB.Recently,PhaB hasalsobeenreported
tobe used inisoniazid, rifampicin andfluoroquinolonesusceptibility
testing of TB [8–13]. However, it still lacks systematic large-scale
clinical studies on PhaB. The purpose of the study is to evaluate the
performance of phage amplified biologically assay (PhaB) for
detecting TB in sputum in the pulmonary tuberculosis (PTB)
patients through multi-center cooperation.
Materials and Methods
Ethics Statement
All these patients were treated in accordance with the Helsinki
Declaration on the participation of human subjects in medical
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24435research. The ethics approvals were obtained for this study from
Tongji University Ethics Committee, Anhui Province Pulmonary
Hospital Province Ethics Committee, Hebei Province Chest Hospital
Ethics Committee, Changchun Infectious Diseases Hospital Ethics
Committee, Jiangxi Province Chest Hospital Ethics Committee,
Tianjin Haihe Hospital Ethics Committee and Chongqing Municipal
Public Health Medical Center Ethics Committee. A written informed
consent was obtained from each of participants.
Study participants
Shanghai Pulmonary Hospital in combination with six other
hospitals of China (Anhui Province Pulmonary Hospital Province,
Hebei Province Chest Hospital, Changchun Infectious Diseases
Hospital, Jiangxi Province Chest Hospital, Tianjin Haihe Hospital
and Chongqing Municipal Public Health Medical Center) partic-
ipated in the project. The unified research plans were carefully
designed. The clinical diagnoses for PTB were conducted by the
physicians accordingtotheguidelinesfordiagnosis andtreatmentof
pulmonary tuberculosis by the Respiratory Disease Branch of the
Chinese Medical Association [14]. The criteria mainly involve
symptoms, radiographic findings (chest X-rays or CT scans),
tuberculin skin tests, a physical examination, and a medical history.
The non-TB patients (having a definite diagnosis of non-TB
pulmonary disease) were randomly selected and included in the
study for the controls. According to the guidelines recommended by
WHO and IUTALD, three sputum samples were collected from
each of the participants. The samples were tested immediately for
smear microscopy, PhaB and Lo ¨wenstein-Jensen (L-J) culture. The
physicians were blinded to the results of the mentioned assays and
the lab staffs were blinded to the diagnosis of the patients. A total of
1660 eligible participants (1351 consecutive PTB patients and 309
random non-TB patients) were included in the study between Jan
Figure 1. The primary procedures of PhaB method for detection of TB.
doi:10.1371/journal.pone.0024435.g001
Table 1. Characteristics of the clinical PTB patients and non-
TB patients.
Characteristics PTB patients Non-TB patients
Total Number 1351 309
Age, Median in years (Range, IQR) 34 (10–87, 21–42) 38 (12–85, 22–45)
Male: female 683:668 167:142
Known previous history of PTB 97 (7.2%) 0






Pneumonia - 115 (37.22%)
Bronchitis - 109 (35.28%)
Lung cancer - 61 (19.74%)
Lung abscess and other - 24 (7.77%)
IQR: inter quartile range.
doi:10.1371/journal.pone.0024435.t001
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participants were given in Table 1. The flow chart of patients
included in the study was shown in Figure 2.
Sputum samples processing
According to the Chinese Anti-tuberculosis Association (CATA)
guidelines, the decontamination of sputum specimen was con-
ducted by 4% NaOH-N-acetyl cysteine methods. Based on the
degree of sputum viscosity, 2 to 4-fold volume of the liquefier was
added. Shook the mixture for 30 s at oscillator and then incubated
it at 37uC for 15 min. Added 5 ml liquid medium, centrifuged and
washed two times. Subsequently, the supernatant was discarded
and the sediment was resuspended in 0.3 ml liquid medium.
Finally, 0.1 ml of the mixture suspension was put onto slides for
homogenous smear preparation and 0.1 ml of the homogenous
suspension was inoculated into L-J slant medium, and 0.1 ml of
the remaining was used for PhaB.
Sputum smear microscopy
The smears were stained by Ziehl-Neelsen (ZN) method
according to World Health Organisation (WHO) standard
protocol [15].
Related reagents and materials preparation for PhaB
Working phage preparation. The procedures referred to
the previous study [13]. Mycobacterium smegmatis (ATCC607), kindly
offered by China General Microbiological Culture Collection
Center (CGMCC), were used for the proliferation of D29
mycobacteriophage (CGMCC) and the filtrate of the
proliferation medium was concentrated via filtering using
0.22 mm sterile filter membrane. Subsequently, the phage titer
was determined. Finally, the phage was adjusted to 10
9 PFU/ml
for the working concentration (stored at 4uC).
The indicator cells preparation. The fast-growing
Mycobacterium smegmatis was used for indicator cells (acceptance
for mycobacteriophage). With the liquid medium, Mycobacterium
smegmatis being in the exponential growth phase were adjusted to
10
9 plaque forming unit (PFU)/ml for the working concentration.
It was stored at 4uC.
Liquid medium. Middlebrook 7H9 culture media were
kindly offered by Difico U.S. and nutritional additives (oleic
acid, catalase, bovine serum albumin and glucose) were purchased
from Sigma. Middlebrook 7H9 liquid medium containing 10% of
the nutrition additives was prepared for the experiment.
Phage inactivator. With sterile distilled water, ferrous
ammonium sulfate (Sigma) was adjusted to 100 mol/L as the
Phage inactivator.
PhaB procedures
The PhaB procedures were referred to the literature [4]. Briefly
introduced as follows: 0.2 ml of the suspension of the processed
sputum sample, after adding 1 ml liquid medium, was solved and
cultured at 37uC for 24 h. 0.1 ml working phage was added and
the medium was incubated at 37uC for 1 h. 0.1 ml phage
inactivator was added into the medium. Subsequently, the mixture
medium was incubated at 37uC for 5 min. Then, added 5 ml
liquid medium and 1 ml indicator cells. With 5 ml 1.5% melted
agar, the mixture was pour into the plate. After a while, the
concretionary plate was incubated at 37uC for overnight.
Meanwhile, on each run the positive and negative controls were
set for verifying the experimental validation.
Observation for the results of PhaB
In positive results more than 20 phage plaques in 1–2 mm
diameter or the transparent color by merging into many plaques
could be seen. In negative results the plaques number appeared in
the plate should be less than 20. The negative control should show
no plaques and the plaques number of the positive control should
be between 20 and 30.
Figure 2. Flow chart of patients included in the study.
doi:10.1371/journal.pone.0024435.g002
Table 2. Performances of the various methods for testing the clinical sputum specimens compared with the reference standard




(n=309) Testing performances (%, excluded K value)
Positive Negative Positive Negative SN (95% Cl) SP (95% Cl) PPV NPV ACC K value
Smear 493 858 0 309 36.5 (33.9–39.1) 100 (98.8–100.0) 100 36 48.3 0.176
L-J culture 509 842 4 305 37.7 (35.1–40.3) 98.7 (96.7–99.6) 99.2 26.6 49 0.178
PhaB 740 611 3 306 54.8 (52.1–57.5) 99 (97.2–99.8) 99.6 33.4 63 0.306
SN: Sensitivity. SP: Specificity. PPV: Positive predictive value. NPV: Negative predictive value.
ACC: Accuracy. Cl: Confidence interval. K value: Kappa value.
doi:10.1371/journal.pone.0024435.t002
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The procedures of L-J culture and observation for the results
were performed according to the CATA guidelines. The
description in detail is as follow: 0.2 ml processed specimens were
inoculated on the slants of L-J medium (Becton Dickinson) and
incubated at 37uC. The slants were inspected every day for first
week and then weekly for 8 weeks. All culture positives were
identified by ZN staining and standard biochemical identification
tests.
Data analysis
In this study, L-J culture was considered as the gold standard.
The performances and comparisons of the test results were
performed using Stata version 9 (Statacorp, Texas, USA).
Results
The sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), accuracy (ACC), and Kappa
value of PhaB, compared with the reference standard defined by
clinical diagnosis, were 54.8 (95% Cl: 52.1–57.5), 99 (95% Cl:
97.2–99.8), 99.6, 33.4, 63% and 0.306, respectively (Table 2). The
sensitivity and ACC of PhaB were higher than that of L-J culture
and smear method (p,0.05).
The testing results stratified by smear microscopy showed that
the sensitivity of PhaB for detecting smear-negative specimens was
higher than that of L-J culture (Table 3).
Compared with gold standard of TB diagnosis, namely L-J
culture, the overall PhaB sensitivity, specificity, PPV, NPV, ACC
and Kappa value were 98.4 (95% Cl: 96.9–99.3), 71.6 (95% Cl:
68.4–74.6), 67.7, 98.7, 81.7% and 0.643, respectively (Table 4);
while the counterparts of smear microscopy was 79.4 (95% Cl:
75.6–82.8), 89.4 (95% Cl: 87.2–91.4), 48.0, 87.8, 85.6% and
0.692, respectively (Table 5). The results showed that PhaB for
detection of PTB was more sensitive than smear microscopy
(p,0.05).
As far as the consuming time was concerned, median time of
PhaB method is 48 hours (inter quartile range [IQR]: 42–
51 hours), whereas that of L-J culture method would take 31.0
days (IQR: 28–35 days). The detection time of PhaB method was
significantly less than that of L-J culture method (p,0.05).
Discussion
Previous small samples reports showed that the PhaB could be
used as a tool of PTB diagnosis indicating that PhaB might be of
potential clinical value [16–19]. In this study, based on the
previous studies, we set up the standard PhaB procedures.
Furthermore, in order to fulfill to the clinical application in large
scale, we made a set of kits (consisting of working phage 1 bottle,
indicator cell 1 bottle, liquid medium 1 bottle, phage inactivator 1
bottle and the controls 2 bottles), which was very convenient for
routine use in common clinical laboratories. To evaluate the
performance of the kits, we combined the six laboratories in
China, as the unified designed project, 1660 sputum samples were
detected by PhaB and culture method, respectively.
In this study, the sensitivity of PhaB, L-J culture and smear
method in comparison with the reference standard defined by
Table 3. Comparison of the results of the sputum specimens from clinical PTB patients between L-J culture and the PhaB assay
stratified by smear microscopy.




404 89 420 73 1.891 0.167
Smear negative
(N=858)
105 753 320 538 144.57 0.000
Total 509 842 740 611 79.448 0.000
doi:10.1371/journal.pone.0024435.t003
Table 4. Performance of PhaB for the detection of the sputum specimens from clinical PTB patients compared with L-J culture
stratified by smear microscopy.
























99 6 221 532 94.3 (88.0–97.9) 70.7 (67.3–73.9) 30.9 98.9 73.5 0.345
Total
(N=1351)
501 8 239 603 98.4 (96.9–99.3) 71.6 (68.4–74.6) 67.7 98.7 81.7 0.643
doi:10.1371/journal.pone.0024435.t004
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suggesting that PhaB had higher sensitivity against the other two
methods. Whereas, according to the testing results stratified by
smear microscopy, out of 858 smear-negative specimens, 320
(37.3%) were positive by PhaB and 105 (12.2%) were confirmed to
be positive by L-J culture. Apparently, the sensitivity of PhaB was
higher than that of L-J culture. Compared with gold standard of
TB diagnosis, namely L-J culture, the overall sensitivity of PhaB
was 98.4%, while that of smear microscopy was 79.4%, indicating
that the overall sensitivity of PhaB was higher than smear
microscopy. Based on the above facts, it could be concluded that
the sensitivity of PhaB was higher than that of L-J culture and
smear microscopy, especially for detection of smear-negative
specimens.
It is the fact that, due to too slow growth, some M. TB clinical
strainsmay lead to false negative results by using L-Jculture method
[20]; however, that doesn’t affect the detection validation of PhaB
method. It is no wonder that 45.2% (611/1351) patients were
negative by using PhaB method. On one hand, phage could only
infect live mycobacteria, if they were killed via the antimicrobials
treatment, the results would reveal negative [19]. On the other
hand, the intermittent discharged mycobacteria could affect the test
results. So, multiple detections in different dates and collecting
qualified specimens are also very important to PhaB method.
As for the evaluation of the specificity of PhaB, the discrepant
results appeared between using clinical diagnosis as standard and
referring to L-J culture. Compared with L-J culture, the overall
specificityofPhaB wasonly71.6%;whileusingtheclinicaldiagnosis
as a reference standard, the specificity was 99%. For several
decades, L-J culture has been considered as a gold standard for the
evaluation of new assays of TB diagnosis. Undoubtedly, a perfect
gold standard testing method should be 100% specificity and 100%
sensitivity. Unfortunately, L-J culture isn’t an ideal gold standard
testing method for TB diagnosis, mainly due to its low sensitivity.
Therefore, we predicted that in this study some true positive results
that could be wrongly tested by PhaB might be mistaken for true
negative results by L-J culture. Surely, such a mistake would lead to
the descent of specificity of PhaB in comparison with the true
specificity value. Of course, considering clinical comprehensive
diagnosis as a reference standard has some limitations, due to its
unknown accuracy. However, a more effective gold reference
standard is expected to be developed in the future, which is vital to
the evaluation of new diagnostic tests for TB.
Theoretically, mycobacteriophages are only able to infect
Mycobacteria, which could ensure the high specificity of PhaB
method. However, PhaB method might produce some very little
false positive or false negative results. The cross reaction (no-
specificity of phage) could occur between MTB and other
Mycobacteria including Mycobacterium smegmatis, Mycobacterium bovis,
Mycobacterium Kansas, and Mycobacterium butyrate [21,22]. This is the
main reason causing the PhaB false-positive in clinical specimens.
In spite of this, the proportion of the other Mycobacteria was very
small, so the overall experiments’ specificity was still higher. In
addition, some technical factors could influence PhaB method,
such as: the sputum pre-treatment quality (incomplete liquefaction
can stop the phage infection), the infection time, concentration
and conditions of mycobacteriophage, and inactivator concentra-
tion and conditions. We recommended that, 4% NaOH-N-acetyl
cysteine methods should be taken as the sputum decontamination,
10
9 PFU/ml D29 mycobacteriophage at 37uC for 60 min as
mycobacteriophage infection conditions, 100 mmol/ml at 37uC
for 5 min as inactivator concentration and conditions. In addition,
we also noticed that a majority of the results of PhaB positive while
L-J culture negative had smaller plaques number (median:
33 PFU, IQR: 22–57 PFU) in this study. However, amongst the
cases of L-J culture positive while PhaB negative, we couldn’t
discern any valuable clues.
As far as consuming time was concerned, median time of PhaB
method needed 48 hours (IQR: 42–51 hours), whereas that of L-J
culture method would consume 31.0 days (IQR: 28–35 days). The
detection time of PhaB method was significantly less than that of
L-J culture method.
In brief, PhaB method is a rapid and sensitive method for
detecting TB in sputum in pulmonary TB patients; particular in
the diagnosis of smear-negative PTB, PhaB method is obviously
more sensitive than L-J culture method.
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